| Use of baked milk challenges and milk ladders in clinical practice: a worldwide survey of healthcare professionals P Athanasopoulou, E Deligianni, T Dean, A Dewey, C Venter Clinical and Experimental Allergy 47 (3), 430-434, 2017 | 37 | 2017 |
| An international survey on the awareness, use, preference, and health perception of novel psychoactive substances (NPS) E Deligianni, JM Corkery, F Schifano, LA Lione Human Psychopharmacology: Clinical and Experimental 32 (3), e2581, 2017 | 22 | 2017 |
| Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances E Deligianni, OJ Daniel, JM Corkery, F Schifano, LA Lione British journal of clinical pharmacology 86 (3), 505-516, 2020 | 18 | 2020 |
| Assessment of the safety signal for the abuse potential of pregabalin and gabapentin using the FAERS database and big data search analytics G Papazisis, D Spachos, S Siafis, N Pandria, E Deligianni, I Tsakiridis, ... Frontiers in Psychiatry 12, 640264, 2021 | 11 | 2021 |
| Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions–A cross-sectional … C Buhl, R Jacobsen, AB Almarsdóttir, S Abtahi, A Andersen, E Deligianni, ... Vaccine 42 (3), 556-563, 2024 | | 2024 |
| Covid–19 impact on mental health, addiction habits, Novel Psychoactive Substances (NPSs) use and associated health risks perception E Deligianni, G Papazisis, F Schifano, A Goulas, L Lione European Drug Utilization Research Group conference 2023., 2023 | | 2023 |
| Use of Novel Psychoactive Substances (NPSs) of Natural Origin in the United Kingdom Population 2022 E Deligianni, L Lione, G Papazisis EACPT Hybrid Meeting–Clinical pharmacology, 2022 | | 2022 |
| Use of Novel Psychoactive Substances (NPSs) of Natural Origin in the United Kingdom Population E Deligianni, L Lione, C Kontogiorgis, G Papazisis, A Goulas, D Lazari EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 78 (SUPPL 1), S132-S133, 2022 | | 2022 |
| Impact of Covid–19 pandemic on Novel Psychoactive Substance (NPS) use, experience and risk awareness E Deligianni, F Schifano, G Papazisis, L Lione VIII International Conference Novel Psychoactive Substances, 2021 | | 2021 |
| A pandemic during the pandemic? Impact of Covid-19 on cannabis use, patterns and settings for drugs use support E Deligianni, L Lione, I Ezquerra-Romano, D de Segovia Vicente VIII International Conference Novel Psychoactive Substances, 2021 | | 2021 |
| USE OF NOVEL PSYCHOACTIVE SUBSTANCES (NPS) OF NATURAL ORIGIN: AN INTERNATIONAL SURVEY E Deligianni, L Lione, C Kontogiorgis, G Papazisis, D Lazari VII International conference on Novel Psychoactive Substances, 2020 | | 2020 |
| Investigating Parents’ Experiences in Re-introducing Baked Milk Foods in Children with Cow's Milk Allergy P Athanasopoulou, H Mackenzie, E Deligianni, T Dean, C Venter Journal of Allergy and Clinical Immunology 141 (2), AB261, 2018 | | 2018 |
| Novel Psychoactive Substance (NPS) awareness, use and health perception following The UK Psychoactive Substances Act 2016 E Deligianni, OJ Daniel, J Corkery, F Schifano, L Lione Fifth International Conference on Novel Psychoactive Substances (NPS), 2017 | | 2017 |
